Showing 1 - 5 of 5
Persistent link: https://www.econbiz.de/10011317852
Persistent link: https://www.econbiz.de/10009692919
Persistent link: https://www.econbiz.de/10009233377
This paper analyzes pharmaceutical pricing between and within countries to achieve second best static and dynamic efficiency. We distinguish countries with and without universal insurance, because insurance undermines patients' price sensitivity, potentially leading to prices above second-best...
Persistent link: https://www.econbiz.de/10012460068
This paper analyzes determinants of ex-manufacturer prices for originator and generic drugs across a large sample of countries. We focus on drugs to treat HIV/AIDS, TB and malaria in middle and low income countries (MLICs), with robustness checks to other therapeutic categories and other...
Persistent link: https://www.econbiz.de/10012461483